Rice Hall James & Associates LLC Increases Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK)

Rice Hall James & Associates LLC boosted its holdings in shares of Scholar Rock Holding Co. (NASDAQ:SRRK) by 3.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 46,000 shares of the company’s stock after purchasing an additional 1,594 shares during the period. Rice Hall James & Associates LLC owned about 0.06% of Scholar Rock worth $383,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its position in Scholar Rock by 16.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,321,471 shares of the company’s stock valued at $156,444,000 after acquiring an additional 1,149,519 shares in the last quarter. Redmile Group LLC boosted its position in Scholar Rock by 0.3% during the 1st quarter. Redmile Group LLC now owns 6,419,610 shares of the company’s stock valued at $114,012,000 after acquiring an additional 17,105 shares in the last quarter. Vanguard Group Inc. boosted its position in Scholar Rock by 4.0% during the 1st quarter. Vanguard Group Inc. now owns 2,969,534 shares of the company’s stock valued at $52,739,000 after acquiring an additional 114,550 shares in the last quarter. Bellevue Group AG boosted its position in Scholar Rock by 1.5% during the 4th quarter. Bellevue Group AG now owns 2,168,925 shares of the company’s stock valued at $40,776,000 after acquiring an additional 31,000 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in shares of Scholar Rock by 31.5% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,430,764 shares of the company’s stock worth $26,898,000 after purchasing an additional 342,690 shares in the last quarter. 91.08% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on SRRK. BMO Capital Markets boosted their price target on Scholar Rock from $31.00 to $34.00 and gave the stock an “outperform” rating in a research report on Friday, August 9th. HC Wainwright reissued a “buy” rating and issued a $30.00 price target on shares of Scholar Rock in a research report on Tuesday, June 25th. Finally, Wedbush reissued an “outperform” rating and issued a $23.00 price target on shares of Scholar Rock in a research report on Thursday, August 8th. Six equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Scholar Rock has an average rating of “Buy” and a consensus price target of $26.43.

Scholar Rock Price Performance

Shares of NASDAQ SRRK opened at $8.26 on Friday. Scholar Rock Holding Co. has a twelve month low of $5.94 and a twelve month high of $21.17. The firm has a market cap of $661.05 million, a P/E ratio of -3.95 and a beta of 0.82. The company has a 50 day moving average of $8.91 and a 200 day moving average of $11.57. The company has a quick ratio of 6.04, a current ratio of 6.04 and a debt-to-equity ratio of 0.36.

Scholar Rock (NASDAQ:SRRK) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.60) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.61) by $0.01. During the same quarter in the previous year, the business earned ($0.47) earnings per share. As a group, research analysts expect that Scholar Rock Holding Co. will post -2.39 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Edward H. Myles sold 9,458 shares of the business’s stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $8.98, for a total value of $84,932.84. Following the completion of the transaction, the chief financial officer now directly owns 201,518 shares in the company, valued at approximately $1,809,631.64. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Scholar Rock news, General Counsel Junlin Ho sold 4,695 shares of the business’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $8.98, for a total transaction of $42,161.10. Following the completion of the sale, the general counsel now directly owns 204,076 shares in the company, valued at approximately $1,832,602.48. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Edward H. Myles sold 9,458 shares of the business’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $8.98, for a total transaction of $84,932.84. Following the sale, the chief financial officer now owns 201,518 shares of the company’s stock, valued at $1,809,631.64. The disclosure for this sale can be found here. Insiders sold a total of 17,919 shares of company stock worth $161,420 in the last three months. Insiders own 26.20% of the company’s stock.

Scholar Rock Company Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.